Rodrigo Espana - Publications

Wake Forest University, Winston-Salem, NC, United States 

55 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Brodnik ZD, Xu W, Batra A, Lewandowski SI, Ruiz CM, Mortensen OV, Kortagere S, Mahler SV, España RA. Chemogenetic manipulation of dopamine neurons dictates cocaine potency at distal dopamine transporters. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 33046544 DOI: 10.1523/JNEUROSCI.0894-20.2020  0.52
2019 Brodnik ZD, Black EM, España RA. Accelerated development of cocaine-associated dopamine transients and cocaine use vulnerability following traumatic stress. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 31539899 DOI: 10.1038/s41386-019-0526-1  0.52
2018 Mahler SV, Brodnik ZD, Cox BM, Buchta WC, Bentzley BS, Quintanilla J, Cope ZA, Lin EC, Riedy MD, Scofield MD, Messinger J, Ruiz CM, Riegel AC, España RA, Aston-Jones G. Chemogenetic Manipulations of Ventral Tegmental Area Dopamine Neurons Reveal Multifaceted Roles in Cocaine Abuse. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 30446532 DOI: 10.1523/JNEUROSCI.0537-18.2018  0.52
2018 Brodnik Z, Batra A, Oleson EB, España RA. Local GABA receptor mediated suppression of dopamine release within the nucleus accumbens. Acs Chemical Neuroscience. PMID 30253088 DOI: 10.1021/acschemneuro.8b00268  0.68
2018 Brodnik ZD, Pamela Alonso I, Xu W, Zhang Y, Kortagere S, España RA. Hypocretin receptor 1 involvement in cocaine-associated behavior: therapeutic potential and novel mechanistic insights. Brain Research. PMID 30071195 DOI: 10.1016/j.brainres.2018.07.027  0.52
2018 Struzyna LA, Browne KD, Brodnik ZD, Burrell JC, Harris JP, Isaac Chen H, Wolf JA, Panzer KV, Lim J, Duda JE, España RA, Kacy Cullen D. Tissue engineered nigrostriatal pathway for treatment of Parkinson's disease. Journal of Tissue Engineering and Regenerative Medicine. PMID 29766664 DOI: 10.1002/term.2698  0.52
2017 Schelp SA, Brodnik ZD, Rakowski DR, Pultorak KJ, Sambells AT, Espana RA, Oleson EB. Diazepam concurrently increases the frequency and decreases the amplitude of dopamine transient release events in the nucleus accumbens. The Journal of Pharmacology and Experimental Therapeutics. PMID 29054857 DOI: 10.1124/jpet.117.241802  0.68
2017 Brodnik ZD, Black EM, Clark MJ, Kornsey KN, Snyder NW, España RA. Susceptibility to traumatic stress sensitizes the dopaminergic response to cocaine and increases motivation for cocaine. Neuropharmacology. PMID 28778834 DOI: 10.1016/j.neuropharm.2017.07.032  0.52
2017 Levy KA, Brodnik ZD, Shaw JK, Perrey DA, Zhang Y, España RA. Hypocretin receptor 1 blockade produces bimodal modulation of cocaine-associated mesolimbic dopamine signaling. Psychopharmacology. PMID 28667509 DOI: 10.1007/s00213-017-4673-y  0.52
2017 Brodnik ZD, Double M, España RA, Jaskiw GE. L-Tyrosine availability affects basal and stimulated catecholamine indices in prefrontal cortex and striatum of the rat. Neuropharmacology. 123: 159-174. PMID 28571714 DOI: 10.1016/j.neuropharm.2017.05.030  0.52
2017 Rao AN, Patil A, Brodnik ZD, Qiang L, Espana RA, Sullivan KA, Black MM, Baas PW. Pharmacologically increasing microtubule acetylation corrects stress-exacerbated effects of organophosphates on neurons. Traffic (Copenhagen, Denmark). PMID 28471062 DOI: 10.1111/tra.12489  0.52
2017 Gentile TA, Simmons SJ, Barker DJ, Shaw JK, España RA, Muschamp JW. Suvorexant, an orexin/hypocretin receptor antagonist, attenuates motivational and hedonic properties of cocaine. Addiction Biology. PMID 28419646 DOI: 10.1111/adb.12507  0.36
2016 Brodnik ZD, Ferris MJ, Jones SR, España RA. Reinforcing Doses of Intravenous Cocaine Produce Only Modest Dopamine Uptake Inhibition. Acs Chemical Neuroscience. PMID 27936579 DOI: 10.1021/acschemneuro.6b00304  1
2016 MacLaren DA, Browne RW, Shaw JK, Krishnan Radhakrishnan S, Khare P, España RA, Clark SD. Clozapine N-Oxide Administration Produces Behavioral Effects in Long-Evans Rats: Implications for Designing DREADD Experiments. Eneuro. 3. PMID 27822508 DOI: 10.1523/ENEURO.0219-16.2016  0.36
2016 Shaw JK, Ferris MJ, Locke JL, Brodnik ZD, Jones SR, España RA. Hypocretin/orexin knock-out mice display disrupted behavioral and dopamine responses to cocaine. Addiction Biology. PMID 27480648 DOI: 10.1111/adb.12432  1
2016 España RA, Schmeichel BE, Berridge CW. Norepinephrine at the Nexus of Arousal, Motivation and Relapse. Brain Research. PMID 26773688 DOI: 10.1016/j.brainres.2016.01.002  1
2015 Bernosky-Smith KA, Stanger DB, Trujillo AJ, Mitchell LR, Espana RA, Bass CE. The GLP-1 agonist exendin-4 attenuates self-administration of sweetened fat on fixed and progressive ratio schedules of reinforcement in rats. Pharmacology, Biochemistry, and Behavior. PMID 26701752 DOI: 10.1016/j.pbb.2015.12.007  1
2015 Brodnik ZD, España RA. Dopamine uptake dynamics are preserved under isoflurane anesthesia. Neuroscience Letters. 606: 129-34. PMID 26321152 DOI: 10.1016/j.neulet.2015.08.046  0.52
2015 Escobar AP, Cornejo FA, Olivares-Costa M, González M, Fuentealba JA, Gysling K, España RA, Andrés ME. Reduced dopamine and glutamate neurotransmission in the nucleus accumbens of quinpirole-sensitized rats hints at inhibitory D2 autoreceptor function. Journal of Neurochemistry. PMID 26112331 DOI: 10.1111/jnc.13209  1
2015 Brodnik ZD, Bernstein DL, Prince CD, España RA. Hypocretin receptor 1 blockade preferentially reduces high effort responding for cocaine without promoting sleep. Behavioural Brain Research. 291: 377-84. PMID 26049058 DOI: 10.1016/j.bbr.2015.05.051  1
2015 Prince CD, Rau AR, Yorgason JT, España RA. Hypocretin/Orexin regulation of dopamine signaling and cocaine self-administration is mediated predominantly by hypocretin receptor 1. Acs Chemical Neuroscience. 6: 138-46. PMID 25496218 DOI: 10.1021/cn500246j  1
2014 Ferris MJ, España RA, Locke JL, Konstantopoulos JK, Rose JH, Chen R, Jones SR. Dopamine transporters govern diurnal variation in extracellular dopamine tone. Proceedings of the National Academy of Sciences of the United States of America. 111: E2751-9. PMID 24979798 DOI: 10.1073/pnas.1407935111  1
2014 Ferris MJ, Milenkovic M, Liu S, Mielnik CA, Beerepoot P, John CE, España RA, Sotnikova TD, Gainetdinov RR, Borgland SL, Jones SR, Ramsey AJ. Sustained N-methyl-d-aspartate receptor hypofunction remodels the dopamine system and impairs phasic signaling. The European Journal of Neuroscience. 40: 2255-63. PMID 24754704 DOI: 10.1111/ejn.12594  1
2013 Ferris MJ, Calipari ES, Melchior JR, Roberts DC, España RA, Jones SR. Paradoxical tolerance to cocaine after initial supersensitivity in drug-use-prone animals. The European Journal of Neuroscience. 38: 2628-36. PMID 23725404 DOI: 10.1111/ejn.12266  1
2013 Yorgason JT, España RA, Konstantopoulos JK, Weiner JL, Jones SR. Enduring increases in anxiety-like behavior and rapid nucleus accumbens dopamine signaling in socially isolated rats. The European Journal of Neuroscience. 37: 1022-31. PMID 23294165 DOI: 10.1111/ejn.12113  1
2013 Espana RA, Jones SR. Presynaptic dopamine modulation by stimulant self-administration. Frontiers in Bioscience (Scholar Edition). 5: 261-76. PMID 23277050  1
2012 Calipari ES, España RA. Hypocretin/orexin regulation of dopamine signaling: implications for reward and reinforcement mechanisms. Frontiers in Behavioral Neuroscience. 6: 54. PMID 22933994 DOI: 10.3389/fnbeh.2012.00054  1
2012 España RA. Hypocretin/orexin involvement in reward and reinforcement. Vitamins and Hormones. 89: 185-208. PMID 22640614 DOI: 10.1016/B978-0-12-394623-2.00010-X  0.92
2012 Oleson EB, Ferris MJ, España RA, Harp J, Jones SR. Effects of the histamine H₁ receptor antagonist and benztropine analog diphenylpyraline on dopamine uptake, locomotion and reward. European Journal of Pharmacology. 683: 161-5. PMID 22445882 DOI: 10.1016/j.ejphar.2012.03.003  1
2012 Berridge CW, Schmeichel BE, España RA. Noradrenergic modulation of wakefulness/arousal. Sleep Medicine Reviews. 16: 187-97. PMID 22296742 DOI: 10.1016/j.smrv.2011.12.003  1
2011 McGinty VB, Hayden BY, Heilbronner SR, Dumont EC, Graves SM, Mirrione MM, du Hoffmann J, Sartor GC, España RA, Millan EZ, Difeliceantonio AG, Marchant NJ, Napier TC, Root DH, Borgland SL, et al. Emerging, reemerging, and forgotten brain areas of the reward circuit: Notes from the 2010 Motivational Neural Networks conference. Behavioural Brain Research. 225: 348-57. PMID 21816177 DOI: 10.1016/j.bbr.2011.07.036  1
2011 España RA, Scammell TE. Sleep neurobiology from a clinical perspective. Sleep. 34: 845-58. PMID 21731134 DOI: 10.5665/SLEEP.1112  1
2011 Yorgason JT, Jones SR, España RA. Low and high affinity dopamine transporter inhibitors block dopamine uptake within 5 sec of intravenous injection. Neuroscience. 182: 125-32. PMID 21402130 DOI: 10.1016/j.neuroscience.2011.03.017  1
2011 Yorgason JT, España RA, Jones SR. Demon voltammetry and analysis software: analysis of cocaine-induced alterations in dopamine signaling using multiple kinetic measures. Journal of Neuroscience Methods. 202: 158-64. PMID 21392532 DOI: 10.1016/j.jneumeth.2011.03.001  1
2011 España RA, Melchior JR, Roberts DC, Jones SR. Hypocretin 1/orexin A in the ventral tegmental area enhances dopamine responses to cocaine and promotes cocaine self-administration. Psychopharmacology. 214: 415-26. PMID 20959967 DOI: 10.1007/s00213-010-2048-8  1
2010 España RA, Oleson EB, Locke JL, Brookshire BR, Roberts DC, Jones SR. The hypocretin-orexin system regulates cocaine self-administration via actions on the mesolimbic dopamine system. The European Journal of Neuroscience. 31: 336-48. PMID 20039943 DOI: 10.1111/j.1460-9568.2009.07065.x  1
2010 Berridge CW, España RA, Vittoz NM. Hypocretin/orexin in arousal and stress. Brain Research. 1314: 91-102. PMID 19748490 DOI: 10.1016/j.brainres.2009.09.019  1
2009 Hampson RE, España RA, Rogers GA, Porrino LJ, Deadwyler SA. Mechanisms underlying cognitive enhancement and reversal of cognitive deficits in nonhuman primates by the ampakine CX717. Psychopharmacology. 202: 355-69. PMID 18985324 DOI: 10.1007/s00213-008-1360-z  1
2009 Stalnaker TA, España RA, Berridge CW. Coping behavior causes asymmetric changes in neuronal activation in the prefrontal cortex and amygdala. Synapse (New York, N.Y.). 63: 82-5. PMID 18932226 DOI: 10.1002/syn.20583  1
2008 España RA, Roberts DC, Jones SR. Short-acting cocaine and long-acting GBR-12909 both elicit rapid dopamine uptake inhibition following intravenous delivery. Neuroscience. 155: 250-7. PMID 18597947 DOI: 10.1016/j.neuroscience.2008.05.022  1
2007 España RA, McCormack SL, Mochizuki T, Scammell TE. Running promotes wakefulness and increases cataplexy in orexin knockout mice. Sleep. 30: 1417-25. PMID 18041476  1
2006 España RA, Berridge CW. Organization of noradrenergic efferents to arousal-related basal forebrain structures. The Journal of Comparative Neurology. 496: 668-83. PMID 16615125 DOI: 10.1002/cne.20946  1
2006 Yoshida K, McCormack S, España RA, Crocker A, Scammell TE. Afferents to the orexin neurons of the rat brain. The Journal of Comparative Neurology. 494: 845-61. PMID 16374809 DOI: 10.1002/cne.20859  1
2005 Crocker A, España RA, Papadopoulou M, Saper CB, Faraco J, Sakurai T, Honda M, Mignot E, Scammell TE. Concomitant loss of dynorphin, NARP, and orexin in narcolepsy. Neurology. 65: 1184-8. PMID 16247044 DOI: 10.1212/01.wnl.0000168173.71940.ab  1
2005 Berridge CW, España RA. Hypocretins: waking, arousal, or action? Neuron. 46: 696-8. PMID 15924855 DOI: 10.1016/j.neuron.2005.05.016  1
2005 España RA, Reis KM, Valentino RJ, Berridge CW. Organization of hypocretin/orexin efferents to locus coeruleus and basal forebrain arousal-related structures. The Journal of Comparative Neurology. 481: 160-78. PMID 15562511 DOI: 10.1002/cne.20369  1
2005 Berridge CW, España RA. Hypocretin/orexin in stress and arousal Hypocretins: Integrators of Physiological Functions. 353-367. DOI: 10.1007/0-387-25446-3_24  1
2004 España RA, Berridge CW, Gammie SC. Diurnal levels of Fos immunoreactivity are elevated within hypocretin neurons in lactating mice. Peptides. 25: 1927-34. PMID 15501524 DOI: 10.1016/j.peptides.2004.06.006  1
2004 España RA, Scammell TE. Sleep neurobiology for the clinician. Sleep. 27: 811-20. PMID 15283019  1
2003 España RA, Valentino RJ, Berridge CW. Fos immunoreactivity in hypocretin-synthesizing and hypocretin-1 receptor-expressing neurons: effects of diurnal and nocturnal spontaneous waking, stress and hypocretin-1 administration. Neuroscience. 121: 201-17. PMID 12946712 DOI: 10.1016/S0306-4522(03)00334-8  1
2003 Berridge CW, Isaac SO, España RA. Additive wake-promoting actions of medial basal forebrain noradrenergic alpha1- and beta-receptor stimulation. Behavioral Neuroscience. 117: 350-9. PMID 12708531 DOI: 10.1037/0735-7044.117.2.350  1
2002 Lin SH, Arai AC, España RA, Berridge CW, Leslie FM, Huguenard JR, Vergnes M, Civelli O. Prolactin-releasing peptide (PrRP) promotes awakening and suppresses absence seizures. Neuroscience. 114: 229-38. PMID 12207968 DOI: 10.1016/S0306-4522(02)00248-8  1
2002 España RA, Plahn S, Berridge CW. Circadian-dependent and circadian-independent behavioral actions of hypocretin/orexin. Brain Research. 943: 224-36. PMID 12101045 DOI: 10.1016/S0006-8993(02)02653-7  1
2001 España RA, Baldo BA, Kelley AE, Berridge CW. Wake-promoting and sleep-suppressing actions of hypocretin (orexin): basal forebrain sites of action. Neuroscience. 106: 699-715. PMID 11682157 DOI: 10.1016/S0306-4522(01)00319-0  1
2000 Berridge CW, España RA. Synergistic sedative effects of noradrenergic alpha(1)- and beta-receptor blockade on forebrain electroencephalographic and behavioral indices. Neuroscience. 99: 495-505. PMID 11029541 DOI: 10.1016/S0306-4522(00)00215-3  1
Show low-probability matches.